Published in J Endourol on January 01, 2010
A prospective, randomized trial comparing the use of KTP (GreenLight) laser versus electroresection-supplemented laser in the treatment of benign prostatic hyperplasia. Cent European J Urol (2016) 1.37
Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer. World J Urol (2011) 1.03
Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol (2010) 0.97
The evolution of lasers in urology. Ther Adv Urol (2011) 0.91
Long-Term Follow-Up Results of Photoselective Vaporization of the Prostate with the 120 W Greenlight HPS Laser for Treatment of Benign Prostatic Hyperplasia. Korean J Urol (2011) 0.91
A rare but serious complication of GreenLight HPS photoselective vaporization of the prostate: Prostatic capsular perforation with bilateral thigh urinomas and osteitis pubis. Can Urol Assoc J (2013) 0.88
Photoselective green-light laser vaporisation vs. TURP for BPH: meta-analysis. Asian J Androl (2012) 0.84
Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials. Lasers Med Sci (2016) 0.79
The 532-nm 180-W (GreenLight®) laser vaporization of the prostate for the treatment of lower urinary tract symptoms: how durable is the new side-fire fiber with integrated cooling system? Lasers Med Sci (2013) 0.78
Photoselective vaporization of the prostate using GreenLight 120-W lithium triborate laser to treat symptomatic benign prostatic hyperplasia: A single-centre prospective study. Can Urol Assoc J (2013) 0.78
The role of lasers in modern urology. Cent European J Urol (2015) 0.77
Vaporization of the prostate with 150-w thulium laser: complications with 6-month follow-up. J Endourol (2014) 0.77
Safety, efficacy and outcomes of the new GreenLight XPS 180W laser system compared to the GreenLight HPS 120W system for the treatment of benign prostatic hyperplasia in a prospective nonrandomized single-centre study. Can Urol Assoc J (2015) 0.77
Photoselective vaporization of the prostate with GreenLight 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis of randomized controlled trials. Lasers Med Sci (2015) 0.77
Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry study. World J Urol (2013) 0.77
Tissue damage by laser radiation: an in vitro comparison between Tm:YAG and Ho:YAG laser on a porcine kidney model. Springerplus (2016) 0.75
Optimising patient outcomes with photoselective vaporization of the prostate (PVP): a review. Transl Androl Urol (2017) 0.75
2007 guideline for the management of ureteral calculi. J Urol (2007) 4.44
2007 Guideline for the management of ureteral calculi. Eur Urol (2007) 3.98
Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Eur Urol (2007) 2.09
Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int (2005) 1.91
980-nm Diode laser: a novel laser technology for vaporization of the prostate. Eur Urol (2007) 1.79
Shock wave technology and application: an update. Eur Urol (2011) 1.77
Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol (2011) 1.55
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol (2009) 1.52
Flexible ureterorenoscopy for the treatment of lower pole calyx stones: influence of different lithotripsy probes and stone extraction tools on scope deflection and irrigation flow. Eur Urol (2002) 1.50
5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. Eur Urol (2005) 1.50
Physiologic bladder evacuation with selective sacral root stimulation: sinusoidal signal and organ-specific frequency. Neurourol Urodyn (2002) 1.41
Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol (2008) 1.40
Radical cystectomy--often too late? 1987. Eur Urol (2006) 1.38
Unfavorable outcomes of laparoscopic pyeloplasty using barbed sutures: a multi-center experience. World J Urol (2013) 1.37
Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer. Int J Cancer (2003) 1.34
High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature. J Urol (2002) 1.33
Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int J Cancer (2008) 1.27
The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. J Pharmacol Exp Ther (2002) 1.27
Urolithiasis through the ages: data on more than 200,000 urinary stone analyses. J Urol (2011) 1.26
Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res (2005) 1.22
Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol (2002) 1.21
Does open stone surgery still play a role in the treatment of urolithiasis? Data of a primary urolithiasis center. J Endourol (2009) 1.18
Three-dimensional laparoscopic imaging improves surgical performance on standardized ex-vivo laparoscopic tasks. J Endourol (2012) 1.17
Low-power holmium:YAG laser urethrotomy for treatment of urethral strictures: functional outcome and quality of life. J Endourol (2006) 1.15
Diverticular carcinoma of the urinary bladder: diagnosis and treatment problems. A case report. Med Princ Pract (2005) 1.13
Standardization strategy for quantitative PCR in human seminoma and normal testis. J Biotechnol (2005) 1.13
Do patients benefit from miniaturized tubeless percutaneous nephrolithotomy? A comparative prospective study. J Endourol (2010) 1.09
Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol (2003) 1.08
Donor-site morbidity in buccal mucosa urethroplasty: lower lip or inner cheek? BJU Int (2005) 1.08
Validation of computer-based training in ureterorenoscopy. BJU Int (2005) 1.08
Regulation of HERG potassium channel activation by protein kinase C independent of direct phosphorylation of the channel protein. Cardiovasc Res (2003) 1.07
70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJU Int (2009) 1.05
Alteration of the LRP1B gene region is associated with high grade of urothelial cancer. Lab Invest (2002) 1.05
The Vista system: a new bipolar resection device for endourological procedures: comparison with conventional resectoscope. Eur Urol (2004) 1.04
Flexible ureterorenoscopy for lower pole stones: influence of the collecting system's anatomy. J Endourol (2013) 1.04
Prospective evaluation of acute endocrine pancreatic injury as collateral damage of shock-wave lithotripsy for upper urinary tract stones. BJU Int (2007) 1.03
A biological model to teach percutaneous nephrolithotomy technique with ultrasound- and fluoroscopy-guided access. J Endourol (2007) 1.02
Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol (2004) 1.02
Human cardiac inwardly-rectifying K+ channel Kir(2.1b) is inhibited by direct protein kinase C-dependent regulation in human isolated cardiomyocytes and in an expression system. Circulation (2002) 1.02
Two contemporary series of percutaneous tract dilation for percutaneous nephrolithotomy. J Endourol (2009) 1.02
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int (2008) 0.99
Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol (2011) 0.99
Extracorporeal application of high-intensity focused ultrasound for prostatic tissue ablation. BJU Int (2005) 0.99
Live surgical education: a perspective from the surgeons who perform it. BJU Int (2014) 0.97
The past, present and future of minimally invasive therapy in urology: a review and speculative outlook. Minim Invasive Ther Allied Technol (2013) 0.97
Prostate cancer therapy: standard management, new options and experimental approaches. Anticancer Res (2005) 0.96
Risk of collateral damage to endourologic tools by holmium:YAG laser energy. J Endourol (2006) 0.93
Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center. J Endourol (2007) 0.92